Stock data
Neuphoria Therapeutics Inc. (NEUP)
Neuphoria Therapeutics Inc. (NEUP) reported revenue of US$1.17M and net income of -US$13.45M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-06-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$1.17M | — | -US$16.45M | -US$13.45M | — |
| 2025 | US$15.65M | — | -US$1.13M | -US$0.37M | — |
| 2024 | — | — | -US$17.89M | -US$15.49M | — |
| 2023 | — | — | -US$21.98M | -US$21.38M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.90M | — |
| 2026-03-31 | — | -US$0.51M | — |
| 2025-12-31 | — | US$1.86M | — |
| 2025-09-30 | — | -US$9.91M | — |
| 2025-06-30 | — | -US$8.88M | — |
| 2025-03-31 | US$15.00M | US$11.26M | — |
| 2024-12-31 | US$0.66M | -US$1.94M | — |
| 2024-09-30 | — | -US$0.80M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.